Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Maraviroc Compassionate Use
NCT00719823Phase 3Withdrawn
- Sponsor
- ViiV Healthcare
- Start
- Aug 2008
- Primary completion
- May 2010
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of maraviroc in human immunodeficiency virus type 1 infection (HIV-1), sponsored by ViiV Healthcare. Planned start Aug 2008; status: withdrawn.
02
Drugs
maraviroc
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT00719823.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00719823.